We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SABSW market cap is 223.34k. The company's latest EPS is USD -3.6954 and P/E is -0.47.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 305k | 945k | 263k | 0 | 114k |
| Operating Income | -18.87M | -11.39M | -10.2M | -11.31M | -10.01M |
| Net Income | -22.86M | -5.03M | -7.34M | -10.35M | -11.39M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 60.88M | 23.9M | 2.24M | 1.32M |
| Operating Income | -9k | -13.39M | -28.92M | -38.08M | -42.91M |
| Net Income | -9k | -17.15M | -18.74M | -42.19M | -34.11M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 83.94M | 71.37M | 61.89M | 53.8M | 44.2M |
| Total Liabilities | 26.64M | 18.55M | 15.77M | 16.89M | 18.23M |
| Total Equity | 57.3M | 52.82M | 46.12M | 36.9M | 25.97M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 322k | 79.37M | 50.91M | 83.94M | 44.2M |
| Total Liabilities | 306k | 40.82M | 19.85M | 26.64M | 18.23M |
| Total Equity | 16k | 38.55M | 31.06M | 57.3M | 25.97M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.12M | -10.75M | -18.47M | -24.76M | -34.29M |
| Investing | -153k | -31.36M | -20.14M | -21.29M | -11.96M |
| Financing | 66.77M | -394k | -715k | -1.39M | -1.17M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10k | 3.76M | -23.46M | -25.12M | -34.29M |
| Investing | N/A | -10.94M | -2.09M | -153k | -11.96M |
| Financing | 95k | 34.12M | 1.05M | 66.77M | -1.17M |
| Market Cap | 223.34k |
| Price to Earnings Ratio | -0.47 |
| Price to Sales Ratio | 12.15 |
| Price to Cash Ratio | 1.8 |
| Price to Book Ratio | 0.62 |
| Dividend Yield | - |
| Shares Outstanding | 9.23M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (33.04%) |
| Company Name | SAB Biotherapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sab.bio |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
